Stockscreener 앱 받기
1.91
1.04%
-0.02
시간 외 거래:
1.90
-0.01
-0.52%
전일 마감가:
$1.93
열려 있는:
$1.93
하루 거래량:
65,726
Relative Volume:
0.12
시가총액:
$4.53M
수익:
$574.20K
순이익/손실:
$-11.52M
주가수익비율:
-0.0417
EPS:
-45.8332
순현금흐름:
$-6.92M
1주 성능:
-5.45%
1개월 성능:
-9.05%
6개월 성능:
-32.98%
1년 성능:
+7.91%
1일 변동 폭
$1.91
$1.97
1주일 범위
$1.81
$2.1299
52주 변동 폭
$0.5079
$5.89
애틀론 메디컬 Stock (AEMD) Company Profile
명칭
Aethlon Medical Inc
전화
619-941-0360
주소
11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA
Compare AEMD vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AEMD
Aethlon Medical Inc
|
1.91 | 4.74M | 574.20K | -11.52M | -6.92M | -45.83 |
ABT
Abbott Laboratories
|
88.50 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
301.14 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.14 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.95 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.68 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
애틀론 메디컬 Stock (AEMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-07 | 재개 | H.C. Wainwright | Neutral |
애틀론 메디컬 주식(AEMD)의 최신 뉴스
AEMD Q1 2026 Earnings: Slight EPS Beat Amid Pre-Revenue Status, Stock Gains Over 6%Revenue Estimate Trend - The League of Women Voters of Texas
AEMD Q1 2026 Earnings: Narrower-than-Expected Loss Lifts SharesEarnings Volatility Report - newsline.com
Aethlon Medical (AEMD) Reports Q4 2026 Progress in Hemopurifier Trials - GuruFocus
Aethlon Medical Q4 2026 Earnings Call Transcript - MarketBeat
Aethlon outlines cohort 3 expansion to 3–6 patients as Hemopurifier oncology trial advances - MSN
Aethlon Medical FY2026 Earnings: Hemopurifier Advances and Financial OverviewNews and Statistics - IndexBox
Aethlon (AEMD) Q4 2026 Earnings Transcript - The Globe and Mail
Aethlon Medical Reports Fiscal 2026 Results, Clinical Progress - TipRanks
Earnings call transcript: Aethlon Medical Q4 2026 reveals financial strides - Investing.com
AEMD: Operating loss narrowed and clinical milestones achieved as Hemopurifier trials advance - TradingView
Aethlon Medical (AEMD) flags going-concern risk while advancing Hemopurifier trials - Stock Titan
AEMD: Operating expenses fell 21.9% and net loss narrowed as clinical and preclinical programs advanced - TradingView
Aethlon Medical Inc FY 2026: Revenue ($7.17M), Net income ($7.15M), EPS ($10.61) — 10-K Summary - TradingView
Earnings call transcript: Aethlon Medical Q4 2026 reveals financial strides By Investing.com - Investing.com Canada
Aethlon Medical | 8-K: Current report - Moomoo
[8-K] AETHLON MEDICAL INC Reports Material Event - Stock Titan
Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update - TradingView
Earnings Scheduled For June 10, 2026 - Benzinga
AEMD: Operating expenses fell 21.9% and net loss improved to $7.2M as clinical programs advanced - TradingView
AEMD Q4'25 Earnings: EPS estimate is (2.17) USD - TradingView
AEMD Q1 2026 Earnings: Narrower-Than-Expected Loss Amid Continued Pre-Revenue StageEarnings Stability Report - newsline.com
Aethlon Medical (AEMD.US) will release its earnings report after market close on June 10. - Moomoo
AEMD News | AETHLON MEDICAL INC (NASDAQ:AEMD) - ChartMill
Aethlon Medical Updates At-The-Market Equity Offering Capacity - TipRanks
Aethlon Medical raises $542,716 capacity under amended ATM prospectus - TradingView
Aethlon Medical (NASDAQ: AEMD) raises ATM capacity to $542,716 - Stock Titan
AEMD (NASDAQ: AEMD) amends ATM prospectus; $542.7K remaining capacity - Stock Titan
Aethlon Medical (AEMD) to Release Fiscal Year-End Results and Ho - GuruFocus
Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026 - Yahoo Finance Singapore
Hear Aethlon explain its 2026 results: investor Q&A call June 10 - Stock Titan
Aethlon Medical Company Profile & Introduction - Moomoo
Aethlon Medical (AEMD) Plunges 24.83% as Stock Breaks Below Key Support LevelsImpulse Wave - The Legal Advocate
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
AEMD Q1 2026 Earnings: Narrower-Than-Expected Loss as Clinical Pipeline Progress ContinuesTangible Book Value - newsline.com
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
AEMD Q1 2026 Earnings: EPS Beats Estimates by 0.75% Amid Revenue Absence, Stock Declines 15.96%EPS Growth Rate - newsline.com
AEMD Stock Pops As Hemopurifier Draws Ebola Outbreak Focus - StocksToTrade
Medical Tech Stock Aethlon Medical (Nasdaq: AEMD) Jumps Amid Escalating Ebola Crisis - Investorideas.com
AEMD Stock Jumps As Hemopurifier Spotlight Returns On Ebola - timothysykes.com
Why Semtech Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket - Benzinga
AEMD Q1 2026 Earnings: Narrower-than-Expected Loss Boosts Investor SentimentCore Business Growth - newsline.com
AEMD Q1 2026 Earnings: Slightly Better Than Expected Loss Amid No RevenueCEO Earnings Statement - newsline.com
AEMD Q1 2026 Earnings: Narrower Slight Loss Surprise Supports Share RecoveryFiscal Year Earnings - Newser
Aethlon Medical (AEMD) Edges Higher, Testing Key Resistance at $2.26Triple EMA - thelegaladvocate.com
AEMD Q1 2026 Earnings: Narrower-Than-Expected Loss Lifts SharesTrader Community Signals - Newser
AEMD Q1 2026 Earnings: Narrower-than-Expected Loss Lifts Shares ModestlyEarnings Recovery Stocks - newsline.com
Aethlon Medical (AEMD) Monitors Ebola Outbreak for Hemopurifier® Applications - GuruFocus
Aethlon Medical monitors Ebola outbreak in Congo, Uganda - Investing.com UK
Aethlon Medical monitors Ebola outbreak in Congo, Uganda By Investing.com - Investing.com South Africa
Aethlon Medical Monitoring Current Ebola Outbreak and Reaffirms Outbreak/Pandemic Preparedness - Yahoo Finance
애틀론 메디컬 (AEMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.43%
자본화:
|
볼륨(24시간):